Investigation of the Frequency of Histopathological Types of Malignant Thyroid Tumors Operated on in Imam Khomeini Hospital, Tehran: a 5-Year Experience

Authors

1 Associate Professor of General & Vascular Surgery, Shahid Beheshti University of Medical Sciences and Health Services, Shohadaye Tajrish Hospital, Tehran, Iran

2 Professional Doctor of Medicine, Bonab

3 Department of Nursing Management, Faculty of Nursing and Midwifery, Iran University of Medical Sciences

4 Professional Doctor of Medicine, Islam Shahr

Abstract
Introduction & Objective: Thyroid cancer affects individuals of any gender and age. Also, its various pathologies have different prognoses and responses to different treatments in addition to age and gender-specific distribution. Therefore, this study was conducted with the aim of investigating the frequency of histopathology of surgically operated malignant thyroid masses and its relationship with age and gender. Materials & Methods: This cross-sectional study was conducted on patients with malignant thyroid masses who underwent surgery at Imam Khomeini Hospital in Tehran between 1991 and 1996. Patients who were diagnosed with malignant thyroid lesions according to the pathology report were included in the study. Also, patients with a history of surgery, previous thyroid malignancy, and incomplete medical information were excluded from the study. Finally, the clinical symptoms, age, and gender of the patients were collected and recorded along with the frequency of the type of thyroid histopathology. Results: In this study, 75 patients (46 women and 29 men) were included in the study. Most of the patients (26%) were 60 years and older and only two patients were under 20 years old. The most common symptoms were neck mass, dysphagia, dysphonia, shortness of breath, and weight loss, respectively. Papillary carcinoma was the most common (55%) and metastasis was the least (7%) histopathology of malignant thyroid masses. Conclusions: The present study showed that in line with previous studies, the prevalence of thyroid cancer is higher in women and the elderly. Also, papillary carcinoma is the most common pathology of malignant thyroid masses.

Keywords


1. Al-Brahim N, Asa SL. Papillary thyroid carcinoma: an overview. Archives of pathology & laboratory medicine. 2006 Jul 1; 130(7): 1057-62.
2. Alzahrani HA. Malignancy in a Solitary Thyroid Nodule: A Retrospective Histopathological Evaluation. International Journal of General Medicine. 2024 Dec 31: 135-40.
3. Zhang B, Wu W, Shang X, Huang D, Liu M, Zong L. Incidence and prognosis of thyroid cancer in children: based on the SEER database. Pediatric Surgery International. 2022 Mar; 38(3): 445-56.
4. Lin B, Ma H, Ma M, Zhang Z, Sun Z, Hsieh IY, Okenwa O, Guan H, Li J, Lv W. The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis. American journal of translational research. 2019; 11(9): 5888.
5. Tofé S, Argüelles I, Forteza A, Álvarez C, Repetto A, Masmiquel L, Rodríguez I, Losada E, Sukunza N, Cabrer M, Sifontes M. Age-standardized incidence, mortality rate, and trend changes of thyroid cancer in the Balearic Islands during the 2000–2020 period: a population-based study. European Thyroid Journal. 2023 Jun 1; 12(3).
6. Amin A, Amjad A, Farman G, Khaliq SU, Amin L, Khan M. Frequency and Type of Thyroid Carcinoma in Patients With Multinodular Goiter. Cureus. 2023 Apr 21; 15(4).
7. Hassan-Kadle MA, Adani AA, Eker HH, Keles E, Muse Osman M, Mahdi Ahmed H, Görçin Karaketir Ş. Spectrum and prevalence of thyroid diseases at a tertiary referral hospital In Mogadishu, Somalia: a retrospective study of 976 cases. International Journal of Endocrinology. 2021 Dec 26; 2021.
8. Vuong HG, Ngo HT, Bychkov A, Jung CK,
Vu TH, Lu KB, Kakudo K, Kondo T. Differences
in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: a systematic review and
meta-analysis. Cancer Cytopathology. 2020 Apr; 128(4): 238-49.
9. Abbasgholizadeh P, Naseri A, Nasiri E, Sadra V. Is Hashimoto thyroiditis associated with increasing
risk of thyroid malignancies? A systematic review and meta-analysis. Thyroid research. 2021 Dec; 14(1): 1-1.
10.       Lau LW, Ghaznavi S, Frolkis AD, Stephenson A, Robertson HL, Rabi DM, Paschke R.
Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic
 review and a meta-analysis. Thyroid Research. 2021 Dec; 14: 1-6.
11.       Crnčić TB, Tomaš MI, Girotto N, Ivanković SG. Risk factors for thyroid cancer: What do we know so far? Acta Clinica Croatica. 2020 Jun; 59(Suppl 1): 66.
12.       Do BA, Payne RJ, Bastianelli M, Mlynarek AM, Tamilia M, Hier M, Forest VI. Is age associated with risk of malignancy in thyroid cancer? Otolaryngology-Head and Neck Surgery. 2014 Nov; 151(5): 746-50.
13.       Na DG, Paik W, Cha J, Gwon HY, Kim SY, Yoo RE. Diagnostic performance of the modified Korean Thyroid Imaging Reporting and Data System for thyroid malignancy according to nodule size: a comparison with five society guidelines. Ultrasonography. 2021 Oct; 40(4): 474.
14.       Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA
otolaryngology–head & neck surgery. 2014 Apr 1; 140(4): 317-22.
15.       Baloch Z, LiVolsi VA. Fifty years of thyroid pathology: Concepts and developments. Human pathology. 2020 Jan 1; 95: 46-54.
16.       Mao J, Zhang Q, Zhang H, Zheng K, Wang R, Wang G. Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Frontiers in endocrinology. 2020 May 15; 11: 265.
17.       Battistella E, Pomba L, Mattara G, Franzato B, Toniato A. Metastases to the thyroid gland: review of incidence, clinical presentation, diagnostic problems and surgery, our experience. Journal of Endocrinological Investigation. 2020 Nov; 43:
1555-60.
18.       Ghossein CA, Khimraj A, Dogan S, Xu B. Metastasis to the thyroid gland: a single-institution 16-year experience. Histopathology. 2021 Mar; 78(4): 508-19.
19.       Wang J, Yu F, Shang Y, Ping Z, Liu L. Thyroid cancer: incidence and mortality trends in China, 2005-2015. Endocrine. 2020 Apr; 68: 163-73.
20.       Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, Dal Maso L. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. The lancet Diabetes & endocrinology. 2021 Apr 1; 9(4): 225-34.
21.       Grussendorf M, Ruschenburg I, Brabant G. Malignancy rates in thyroid nodules: a long-term cohort study of 17,592 patients. European Thyroid Journal. 2022 Aug 1; 11(4).
22.       Siegel RL, Miller KD, Fuchs HE, Jemal A.
Cancer statistics, 2021. Ca Cancer J Clin. 2021 Jan 12; 71(1): 7-33.